AGT and Hypertension: Given the role of angiotensin II in hypertension-induced cerebrovascular dysfunction, a plausible explanatory mechanism for the association between RAS-targeted agents and favorable functional outcomes after nonlobar ICH may be a salutary benefit for hypertensive CSVD.